Retraction Note: Orphan receptor ligand discovery by pickpocketing pharmacological neighbors (Nature Chemical Biology, (2017), 13, 2, (235-242), 10.1038/nchembio.2266);Orphan receptor ligand discovery by pickpocketing pharmacological neighbors

Nature Chemical Biology

Volumn 13, Issue 2, 2017, Pages 235-242

  Ngo, Tony ^a,b   Ilatovskiy, Andrey V ^c   Stewart, Alastair G ^a,b   Coleman, James L J ^a,b   McRobb, Fiona M ^c   Riek, R Peter ^a   Graham, Robert M ^a,b   Abagyan, Ruben ^c   Kufareva, Irina ^c   Smith, Nicola J ^a,b  

^a VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; LIGAND;

AMINO ACID COMPOSITION; ARTICLE; BINDING SITE; CRYSTAL STRUCTURE; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN INTERACTION; SEQUENCE ALIGNMENT; ANTAGONISTS AND INHIBITORS; CHEMICAL STRUCTURE; DRUG DEVELOPMENT; HEK293 CELL LINE; HUMAN;

DRUG DISCOVERY; HEK293 CELLS; HUMANS; LIGANDS; MOLECULAR STRUCTURE; RECEPTORS, G-PROTEIN-COUPLED;

EID: 85006493380     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/s41589-021-00746-1     Document Type: Erratum

References (49)

1. Davenport, A.P. et al. International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands. Pharmacol. Rev. 65, 967-986 (2013).
2. Southern, C. et al. Screening β-Arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors. J. Biomol. Screen. 18, 599-609 (2013).
3. Jenkins, L. et al. Identification of novel species-selective agonists of the G-protein-coupled receptor GPR35 that promote recruitment of β-Arrestin-2 and activate Gα13. Biochem. J. 432, 451-459 (2010).
4. Kroeze, W.K. et al. PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome. Nat. Struct. Mol. Biol. 22, 362-369 (2015).
5. Ngo, T. et al. Identifying ligands at orphan GPCRs: current status using structure-based approaches. Br. J. Pharmacol. 173, 2934-2951 (2016).
6. Fredriksson, R., Lagerström, M.C., Lundin, L.G. & Schiöth, H.B. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol. Pharmacol. 63, 1256-1272 (2003).
7. Schiöth, H.B. & Fredriksson, R. The GRAFS classification system of G-protein coupled receptors in comparative perspective. Gen. Comp. Endocrinol. 142, 94-101 (2005).
8. Guba, W. et al. From astemizole to a novel hit series of small-molecule somatostatin 5 receptor antagonists via GPCR affinity profiling. J. Med. Chem. 50, 6295-6298 (2007).
9. Martin, R.E., Green, L.G., Guba, W., Kratochwil, N. & Christ, A. Discovery of the first nonpeptidic, small-molecule, highly selective somatostatin receptor subtype 5 antagonists: A chemogenomics approach. J. Med. Chem. 50, 6291-6294 (2007).
10. Scholten, D.J. et al. Pharmacological modulation of chemokine receptor function. Br. J. Pharmacol. 165, 1617-1643 (2012).
11. Lin, H., Sassano, M.F., Roth, B.L. & Shoichet, B.K. A pharmacological organization of G protein-coupled receptors. Nat. Methods 10, 140-146 (2013).
12. van der Horst, E. et al. A novel chemogenomics analysis of G protein-coupled receptors (GPCRs) and their ligands: A potential strategy for receptor de-orphanization. BMC Bioinformatics 11, 316 (2010).
13. Surgand, J.S., Rodrigo, J., Kellenberger, E. & Rognan, D. A chemogenomic analysis of the transmembrane binding cavity of human G-protein-coupled receptors. Proteins 62, 509-538 (2006).
14. Jacoby, E. A novel chemogenomics knowledge-based ligand design strategy-Application to G protein-coupled receptors. Mol. Inform. 20, 115-123 (2001).
15. Gloriam, D.E., Foord, S.M., Blaney, F.E. & Garland, S.L. Definition of the G protein-coupled receptor transmembrane bundle binding pocket and calculation of receptor similarities for drug design. J. Med. Chem. 52, 4429-4442 (2009).
16. Kufareva, I., Ilatovskiy, A.V. & Abagyan, R. Pocketome: An encyclopedia of small-molecule binding sites in 4D. Nucleic Acids Res. 40, D535-D540 (2012).
17. Venkatakrishnan, A.J. et al. Molecular signatures of G protein-coupled receptors. Nature 494, 185-194 (2013).
18. Isberg, V. et al. Generic GPCR residue numbers-Aligning topology maps while minding the gaps. Trends Pharmacol. Sci. 36, 22-31 (2015).
19. Nandigam, R.K., Kim, S., Singh, J. & Chuaqui, C. Position specific interaction dependent scoring technique for virtual screening based on weighted protein-ligand interaction fingerprint profiles. J. Chem. Inf. Model. 49, 1185-1192 (2009).
20. Marcou, G. & Rognan, D. Optimizing fragment and scaffold docking by use of molecular interaction fingerprints. J. Chem. Inf. Model. 47, 195-207 (2007).
21. Sokal, R.R. & Michener, C.D. A statistical method for evaluating systematic relationships. Univ. Kans. Sci. Bull. 38, 1409-1438 (1958).
22. Keiser, M.J. et al. Predicting new molecular targets for known drugs. Nature 462, 175-181 (2009).
23. Modi, M.E. et al. Melanocortin receptor agonists facilitate oxytocin-dependent partner preference formation in the prairie vole. Neuropsychopharmacology 40, 1856-1865 (2015).
24. Bento, A.P. et al. The ChEMBL bioactivity database: An update. Nucleic Acids Res. 42, D1083-D1090 (2014).
25. Kufareva, I., Katritch, V., Stevens, R.C. & Abagyan, R. Advances in GPCR modeling evaluated by the GPCR Dock 2013 assessment: meeting new challenges. Structure 22, 1120-1139 (2014).
26. Kufareva, I., Rueda, M., Katritch, V., Stevens, R.C. & Abagyan, R. Status of GPCR modeling and docking as reflected by community-wide GPCR Dock 2010 assessment. Structure 19, 1108-1126 (2011).
27. Thelen, M. & Thelen, S. CXCR7, CXCR4 and CXCL12: An eccentric trio? J. Neuroimmunol. 198, 9-13 (2008).
28. Min, K.D. et al. Identification of genes related to heart failure using global gene expression profiling of human failing myocardium. Biochem. Biophys. Res. Commun. 393, 55-60 (2010).
29. Marazziti, D. et al. Precocious cerebellum development and improved motor functions in mice lacking the astrocyte cilium-, patched 1-Associated Gpr37l1 receptor. Proc. Natl. Acad. Sci. USA 110, 16486-16491 (2013).
30. Smith, N.J. Drug discovery opportunities at the endothelin B receptor-related orphan G protein-coupled receptors, GPR37 and GPR37L1. Front. Pharmacol. 6, 275 (2015).
31. Leng, N., Gu, G., Simerly, R.B. & Spindel, E.R. Molecular cloning and characterization of two putative G protein-coupled receptors which are highly expressed in the central nervous system. Brain Res. Mol. Brain Res. 69, 73-83 (1999).
32. Valdenaire, O. et al. A new family of orphan G protein-coupled receptors predominantly expressed in the brain. FEBS Lett. 424, 193-196 (1998).
33. Shihoya, W. et al. Activation mechanism of endothelin ETB receptor by endothelin-1. Nature 537, 363-368 (2016).
34. Coleman, J.L. et al. Metalloprotease cleavage of the N terminus of the orphan G protein-coupled receptor GPR37L1 reduces its constitutive activity. Sci. Signal. 9, ra36 (2016).
35. Ngo, T., Coleman, J.L. & Smith, N.J. Using constitutive activity to define appropriate high-Throughput screening assays for orphan G protein-coupled receptors. Methods Mol. Biol. 1272, 91-106 (2015).
36. Sassano, M.F., Doak, A.K., Roth, B.L. & Shoichet, B.K. Colloidal aggregation causes inhibition of G protein-coupled receptors. J. Med. Chem. 56, 2406-2414 (2013).
37. Rezgaoui, M. et al. The neuropeptide head activator is a high-Affinity ligand for the orphan G-protein-coupled receptor GPR37. J. Cell Sci. 119, 542-549 (2006).
38. Civelli, O. et al. G protein-coupled receptor deorphanizations. Annu. Rev. Pharmacol. Toxicol. 53, 127-146 (2013).
39. Isberg, V. et al. Computer-Aided discovery of aromatic l-α-Amino acids as agonists of the orphan G protein-coupled receptor GPR139. J. Chem. Inf. Model. 54, 1553-1557 (2014).
40. Liu, C. et al. GPR139, an orphan receptor highly enriched in the habenula and septum, is activated by the essential amino acids l-Tryptophan and l-phenylalanine. Mol. Pharmacol. 88, 911-925 (2015).
41. Huang, X.P. et al. Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65. Nature 527, 477-483 (2015).
42. Tagat, J.R. et al. Piperazine-based CCR5 antagonists as HIV-1 inhibitors. I: 2(S)-methyl piperazine as a key pharmacophore element. Bioorg. Med. Chem. Lett. 11, 2143-2146 (2001).
43. Alexander, S.P. et al. The concise guide to PHARMACOLOGY 2015/16: G protein-coupled receptors. Br. J. Pharmacol. 172, 5744-5869 (2015).
44. Kufareva, I. & Abagyan, R. in Homology Modelling: Methods and Protocols Vol. 857 (eds Orry, A.J.W. & Abagyan, R.) Ch. 10 (Humana Press, 2012).
45. McRobb, F.M., Sahagún, V., Kufareva, I. & Abagyan, R. In silico analysis of the conservation of human toxicity and endocrine disruption targets in aquatic species. Environ. Sci. Technol. 48, 1964-1972 (2014).
46. Gonnet, G.H., Cohen, M.A. & Benner, S.A. Exhaustive matching of the entire protein sequence database. Science 256, 1443-1445 (1992).
47. Abagyan, R., Totrov, M. & Kuznetsov, D. ICM-A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation. J. Comput. Chem. 15, 488-506 (1994).
48. Paradis, E., Claude, J. & Strimmer, K. APE: Analyses of phylogenetics and evolution in R language. Bioinformatics 20, 289-290 (2004).
49. Abagyan, R., Chen, W. & Kufareva, I. in Computational Approaches to Nuclear Receptors (eds. Cozzini, P. & Kellogg, G.E.) 84-109 (The Royal Society of Chemistry, 2012).